- Release Date: 05/09/24 16:10
- Summary: Immuron Plans Phase 2 Trial for IMM-529 following FDA review
- Price Sensitive: Yes
- Download Document 377.73KB
- Forums
- ASX - By Stock
- Ann: Immuron Plans Phase 2 Trial for IMM-529 following FDA review
Ann: Immuron Plans Phase 2 Trial for IMM-529 following FDA review
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8620 | 8.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 49999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8620 | 0.086 |
4 | 110684 | 0.085 |
3 | 68975 | 0.084 |
1 | 12048 | 0.083 |
1 | 12195 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 49999 | 1 |
0.090 | 69300 | 1 |
0.093 | 81731 | 1 |
0.098 | 36500 | 1 |
0.099 | 105817 | 1 |
Last trade - 07.00am 09/10/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
Day chart unavailable
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online